SCHEMBL7714843

SCHEMBL7714843

CCSc1ccc(-c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.53
RXRB P28702 2/20 0.53
RARB P10826 9/20 0.51
HTT P42858 1/20 0.50
ALDH1A1 P00352 2/20 0.49
BCL2 P10415 1/20 0.49
MEN1 O00255 1/20 0.49
RARA P10276 1/20 0.49
MAPT P10636 1/20 0.49
MTOR P42345 1/20 0.49
KMT2A Q03164 1/20 0.49
BCL2L1 Q07817 1/20 0.48
BAD Q92934 1/20 0.48
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL504032 0.94 HTT (0.55) RXRARXRBHTTALDH1A1NPC1
SCHEMBL10536373 0.93 HAO1 (0.54) RXRARXRBRARBHTTALDH1A1
SCHEMBL10527851 0.85 RARB (0.53) RXRARXRBRARBHTTALDH1A1
SCHEMBL10528505 0.82 RARB (0.58) RXRARXRBRARBALDH1A1MEN1
SCHEMBL10527437 0.81 RARB (0.59) RARBALDH1A1MEN1RARAMAPT
SCHEMBL9793575 0.81 SLC6A4 (0.50) NPC1RAB9A
SCHEMBL10529851 0.80 RARB (0.61) RARBALDH1A1MEN1RARAMAPT
SCHEMBL10528096 0.80 RARB (0.61) RARBALDH1A1MEN1RARAMAPT
SCHEMBL10536522 0.80 RARB (0.61) RARBALDH1A1MEN1RARAMAPT
SCHEMBL10527690 0.80 RARB (0.61) RARBALDH1A1MEN1RARAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376515-B2 DERIVATIVES OF A 2-((4-AMIDINYLPHENYL)-CARBONYLAMINO-1,2-PHENYLENE)-CARBONYLAMINO-) PYRIDINE; POTENT AND HIGHLY SELECTIVE ANTICOAGULANTS; BIOAVAILABILITY AND/OR SOLUBILITY; PREVENTION AND TREATMENT OF THROMBOSIS AND COAGULATION COR THERAPEUTICS, INC. 2002-04-23 US disclosed
EP-0334925-A1 FERROELECTRIC LIQUID CRYSTALLINE PHASES MERCK PATENT GmbH (DE) 1989-10-04 EP disclosed